Yaacov-Garbeli Dana bought ENTX

May 7, 2026 · Form 4 insider transaction

Yaacov-Garbeli Dana bought 58,394 shares of Entera Bio Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
58,394
Price
$0.00
Total value
N/A
Role
SecurityOrdinary Shares, par value NIS 0.0000769 per share
Transaction codeA: Grant or award
Transaction dateMay 7, 2026
Filing dateMay 8, 2026
Shares owned after171,441
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on May 7, 2026. This grant was awarded to the Reporting Person in lieu of a cash bonus the Reported Person was otherwise entitled to. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on May 1, 2026.; These shares are owned by A2Z Counseling Ltd. of which the reporting person owns a 33.33% interest and has effective control over voting and disposition of the shares. The reporting person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

View the original Form 4 on SEC EDGAR